0.3376
Applied Dna Sciences Inc stock is traded at $0.3376, with a volume of 6.04M.
It is up +3.43% in the last 24 hours and down -62.49% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$0.3264
Open:
$0.3499
24h Volume:
6.04M
Relative Volume:
4.36
Market Cap:
$2.19M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-0.6138
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
-37.95%
1M Performance:
-62.49%
6M Performance:
-95.56%
1Y Performance:
-98.88%
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
APDN
Applied Dna Sciences Inc
|
0.3376 | 3.54M | 9.00M | -7.21M | -7.59M | -0.55 |
![]()
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-12-21 | Initiated | ROTH Capital | Buy |
Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
Jul-02-20 | Initiated | H.C. Wainwright | Buy |
Nov-14-16 | Reiterated | Maxim Group | Buy |
May-13-16 | Reiterated | Maxim Group | Buy |
Oct-08-15 | Reiterated | Maxim Group | Buy |
May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
Feb-10-15 | Reiterated | Maxim Group | Buy |
Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 - Lohud
Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World
APDN Trading Halted as Market Awaits Significant Announcement | APDN Stock News - GuruFocus
APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Nigeria
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Reno Gazette Journal
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 | APDN Stock News - GuruFocus
Applied DNA Sets Reverse Stock Split for June 2, Moves Key Investor Call to June 17 - Stock Titan
Applied DNA Sciences Approves Reverse Stock Split - TipRanks
Applied DNA Sciences (APDN) to Implement 1-for-15 Reverse Stock Split | APDN Stock News - GuruFocus
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 | APDN Stock News - GuruFocus
Applied DNA Sciences Announces Major 1:15 Reverse SplitShares Drop from 7.8M to 519K in Nasdaq Bid - Stock Titan
Applied DNA Sciences (NASDAQ:APDN) Stock Rating Lowered by Wall Street Zen - Defense World
Applied DNA Sciences Holds Annual Stockholder Meeting - TipRanks
APDN stock plunges to 52-week low of $0.62 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low of $0.62 amid market challenges - Investing.com Australia
Applied DNA Sciences Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Applied DNA Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot - CT Insider
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results | APDN Stock News - GuruFocus
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Jonesboro Sun
Applied DNA to Announce Second Quarter Fiscal 2025 Financial Res - GuruFocus
Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3 - ACCESS Newswire
Applied DNA Announces Double Update: Q2 Earnings Plus Special Strategic Priorities Discussion - Stock Titan
Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX
Applied DNA Sciences Inc expected to post a loss of $3.00 a shareEarnings Preview - TradingView
Geode Capital Management LLC Grows Holdings in Applied DNA Sciences, Inc. (NASDAQ:APDN) - Defense World
Applied Dna Sciences Inc (APDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Applied DNA Sciences (APDN) to Release Quarterly Earnings on Friday - Defense World
Investing in Applied Dna Sciences Inc (APDN) Is Getting More Attractive - knoxdaily.com
Ratios Revealed: Decoding Applied Dna Sciences Inc (APDN)’s Financial Health - DWinneX
Financial Analysis: Applied Dna Sciences Inc (APDN)’s Ratios Unveil Key Insights - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - ACCESS Newswire
Analysts Say Applied Dna Sciences Inc (NASDAQ:APDN) Can Really Get To 1.5 In 12 Months - Marketing Sentinel
Applied Dna Sciences Inc [APDN] Investment Appeal on the Rise - knoxdaily.com
Market Highlights: Applied Dna Sciences Inc (APDN) Ends on a High Note at 0.90 - DWinneX
Applied Dna Sciences Inc (APDN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
APDN’s earnings estimates: Are they on track to meet expectations? - uspostnews.com
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genetic Medicine Platforms | APDN Stock News - GuruFocus
Applied DNA secures U.S. supply chain for key materials By Investing.com - Investing.com Canada
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):